Ventana Biotech Stock Volatility
| VNTA Stock | USD 0.0004 0.00 0.00% |
Ventana Biotech is out of control given 3 months investment horizon. Ventana Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 12.93% are justified by taking the suggested risk. Use Ventana Biotech Risk Adjusted Performance of 0.0949, semi deviation of 17.44, and Coefficient Of Variation of 902.67 to evaluate company specific risk that cannot be diversified away. Key indicators related to Ventana Biotech's volatility include:
480 Days Market Risk | Chance Of Distress | 480 Days Economic Sensitivity |
Ventana Biotech Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Ventana daily returns, and it is calculated using variance and standard deviation. We also use Ventana's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Ventana Biotech volatility.
Ventana |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Ventana Biotech can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Ventana Biotech at lower prices to lower their average cost per share. Similarly, when the prices of Ventana Biotech's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against Ventana Pink Sheet
| 0.84 | HD | Home Depot | PairCorr |
| 0.79 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.78 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.77 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.77 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.74 | HPQ | HP Inc | PairCorr |
| 0.71 | SYM | Symbotic Trending | PairCorr |
| 0.7 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.69 | T | ATT Inc Aggressive Push | PairCorr |
Ventana Biotech Market Sensitivity And Downside Risk
Ventana Biotech's beta coefficient measures the volatility of Ventana pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Ventana pink sheet's returns against your selected market. In other words, Ventana Biotech's beta of -12.85 provides an investor with an approximation of how much risk Ventana Biotech pink sheet can potentially add to one of your existing portfolios. Ventana Biotech is showing large volatility of returns over the selected time horizon. Ventana Biotech appears to be a penny stock. Although Ventana Biotech may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Ventana Biotech or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Ventana instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Ventana Biotech Demand TrendCheck current 90 days Ventana Biotech correlation with market (Dow Jones Industrial)Ventana Beta |
Ventana standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 114.71 |
It is essential to understand the difference between upside risk (as represented by Ventana Biotech's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Ventana Biotech's daily returns or price. Since the actual investment returns on holding a position in ventana pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Ventana Biotech.
Ventana Biotech Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Ventana Biotech pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Ventana Biotech's price changes. Investors will then calculate the volatility of Ventana Biotech's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Ventana Biotech's volatility:
Historical Volatility
This type of pink sheet volatility measures Ventana Biotech's fluctuations based on previous trends. It's commonly used to predict Ventana Biotech's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Ventana Biotech's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Ventana Biotech's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Ventana Biotech Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Ventana Biotech Projected Return Density Against Market
Given the investment horizon of 90 days Ventana Biotech has a beta of -12.8509 . This entails as returns on its benchmark rise, returns on holding Ventana Biotech are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Ventana Biotech is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ventana Biotech or Financial Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ventana Biotech's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ventana pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Ventana Biotech has an alpha of 14.1553, implying that it can generate a 14.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Ventana Biotech Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Ventana Biotech Pink Sheet Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Ventana Biotech is 887.16. The daily returns are distributed with a variance of 13159.0 and standard deviation of 114.71. The mean deviation of Ventana Biotech is currently at 32.14. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α | Alpha over Dow Jones | 14.16 | |
β | Beta against Dow Jones | -12.85 | |
σ | Overall volatility | 114.71 | |
Ir | Information ratio | 0.11 |
Ventana Biotech Pink Sheet Return Volatility
Ventana Biotech historical daily return volatility represents how much of Ventana Biotech pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 114.7127% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7626% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Ventana Biotech Volatility
Volatility is a rate at which the price of Ventana Biotech or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Ventana Biotech may increase or decrease. In other words, similar to Ventana's beta indicator, it measures the risk of Ventana Biotech and helps estimate the fluctuations that may happen in a short period of time. So if prices of Ventana Biotech fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland. Ventana Biotech is traded on OTC Exchange in the United States.
Ventana Biotech's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Ventana Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Ventana Biotech's price varies over time.
3 ways to utilize Ventana Biotech's volatility to invest better
Higher Ventana Biotech's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Ventana Biotech stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Ventana Biotech stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Ventana Biotech investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Ventana Biotech's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Ventana Biotech's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Ventana Biotech Investment Opportunity
Ventana Biotech has a volatility of 114.71 and is 150.93 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Ventana Biotech. You can use Ventana Biotech to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Ventana Biotech to be traded at $4.0E-4 in 90 days.Good diversification
The correlation between Ventana Biotech and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ventana Biotech and DJI in the same portfolio, assuming nothing else is changed.
Ventana Biotech Additional Risk Indicators
The analysis of Ventana Biotech's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Ventana Biotech's investment and either accepting that risk or mitigating it. Along with some common measures of Ventana Biotech pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0949 | |||
| Market Risk Adjusted Performance | (0.97) | |||
| Mean Deviation | 31.69 | |||
| Semi Deviation | 17.44 | |||
| Downside Deviation | 62.17 | |||
| Coefficient Of Variation | 902.67 | |||
| Standard Deviation | 113.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Ventana Biotech Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Ventana Biotech as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Ventana Biotech's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Ventana Biotech's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Ventana Biotech.
Complementary Tools for Ventana Pink Sheet analysis
When running Ventana Biotech's price analysis, check to measure Ventana Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventana Biotech is operating at the current time. Most of Ventana Biotech's value examination focuses on studying past and present price action to predict the probability of Ventana Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventana Biotech's price. Additionally, you may evaluate how the addition of Ventana Biotech to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |